JAGUAR HEALTH, INC. Revenue
JAGUAR HEALTH, INC. (JAGX) reported Revenue of $1.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-19
- JAGUAR HEALTH, INC. revenues for the quarter ending 2026-06-30 was $1.23M, a 58.88% decline year-over-year.
- JAGUAR HEALTH, INC. revenues for the quarter ending 2026-03-31 was $20.27M, a 815.63% increase year-over-year.
- JAGUAR HEALTH, INC. revenues for the quarter ending 2025-12-31 was $3.23M, a 7.81% decline year-over-year.
- JAGUAR HEALTH, INC. revenues for the quarter ending 2025-09-30 was $3.08M, a 0.80% decline year-over-year.
- JAGUAR HEALTH, INC. revenues for fiscal 2025 was $11.51M, a 1.52% decline from fiscal 2024.
- JAGUAR HEALTH, INC. revenues for fiscal 2024 was $11.69M, a 19.75% increase from fiscal 2023.
- JAGUAR HEALTH, INC. revenues for fiscal 2023 was $9.76M, a 18.36% decline from fiscal 2022.
- JAGUAR HEALTH, INC. revenues for fiscal 2022 was $11.96M, a 175.80% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.23M 10-Q · filed 2026-08-19 | $21.50M 10-Q · filed 2026-08-19 | $24.73M derived: sum of 3 quarters · filed 2026-08-19 | $27.82M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $20.27M 10-Q · filed 2026-05-20 | $23.51M derived: sum of 2 quarters · filed 2026-05-20 | $26.59M derived: sum of 3 quarters · filed 2026-05-20 | $29.57M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $6.32M derived: sum of 2 quarters · filed 2026-04-07 | $9.30M derived: sum of 3 quarters · filed 2026-08-19 | $11.51M 10-K · filed 2026-04-07 | ||||
| 2025-09-30 | $3.08M 10-Q · filed 2025-11-14 | $6.06M derived: sum of 2 quarters · filed 2026-08-19 | $8.28M 10-Q · filed 2025-11-14 | $11.79M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | $2.98M 10-Q · filed 2026-08-19 | $5.19M 10-Q · filed 2026-08-19 | $8.70M derived: sum of 3 quarters · filed 2026-08-19 | $11.81M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | $2.21M 10-Q · filed 2026-05-20 | $5.72M derived: sum of 2 quarters · filed 2026-05-20 | $8.83M derived: sum of 3 quarters · filed 2026-05-20 | $11.55M derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | $3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $6.62M derived: sum of 2 quarters · filed 2026-04-07 | $9.34M derived: sum of 3 quarters · filed 2026-04-07 | $11.69M 10-K · filed 2026-04-07 | ||||
| 2024-09-30 | $3.11M 10-Q · filed 2025-11-14 | $5.83M derived: sum of 2 quarters · filed 2025-11-14 | $8.18M 10-Q · filed 2025-11-14 | $10.48M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $2.72M 10-Q · filed 2025-08-14 | $5.07M 10-Q · filed 2025-08-14 | $7.37M derived: sum of 3 quarters · filed 2025-08-14 | $10.19M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $2.35M 10-Q · filed 2025-05-15 | $4.65M derived: sum of 2 quarters · filed 2025-05-15 | $7.46M derived: sum of 3 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.11M derived: sum of 2 quarters · filed 2025-03-31 | $9.76M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $2.81M 10-Q · filed 2024-11-13 | $7.46M 10-Q · filed 2024-11-13 | ||||||
| 2022-12-31 | $11.96M 10-K · filed 2023-03-24 | |||||||
| 2021-12-31 | $4.33M 10-K · filed 2023-03-24 | |||||||
| 2020-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $5.35M derived: sum of 2 quarters · filed 2021-03-31 | $8.52M derived: sum of 3 quarters · filed 2021-03-31 | $9.38M 10-K · filed 2021-03-31 | ||||
| 2020-09-30 | $2.77M 10-Q · filed 2020-11-16 | $5.94M derived: sum of 2 quarters · filed 2020-11-16 | $6.81M 10-Q · filed 2020-11-16 | $8.32M derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2020-06-30 | $3.17M 10-Q · filed 2020-08-13 | $4.04M 10-Q · filed 2020-08-13 | $5.54M derived: sum of 3 quarters · filed 2021-03-31 | $6.52M derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2020-03-31 | $869.00K 10-Q · filed 2020-05-15 | $2.38M derived: sum of 2 quarters · filed 2021-03-31 | $3.35M derived: sum of 3 quarters · filed 2021-03-31 | $5.05M derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2019-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $2.48M derived: sum of 2 quarters · filed 2021-03-31 | $4.19M derived: sum of 3 quarters · filed 2021-03-31 | $5.78M 10-K · filed 2021-03-31 | $5.78M 10-K · filed 2020-04-03 | |||
| 2019-09-30 | $973.00K 10-Q · filed 2020-11-16 | $972.78K 10-Q · filed 2019-11-14 | $2.68M derived: sum of 2 quarters · filed 2020-11-16 | $4.27M 10-Q · filed 2020-11-16 | $4.27M 10-Q · filed 2019-11-14 | $5.86M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $1.71M 10-Q · filed 2020-08-13 | $1.71M 10-Q · filed 2019-08-14 | $3.29M 10-Q · filed 2020-08-13 | $3.30M 10-Q · filed 2019-08-14 | $4.89M derived: sum of 3 quarters · filed 2020-08-13 | $6.02M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $1.59M 10-Q · filed 2020-05-15 | $1.59M 10-Q · filed 2019-05-21 | $3.19M derived: sum of 2 quarters · filed 2020-05-15 | $4.32M derived: sum of 3 quarters · filed 2020-05-15 | $5.20M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $2.73M derived: sum of 2 quarters · filed 2020-04-03 | $3.61M derived: sum of 3 quarters · filed 2020-04-03 | $4.42M 10-K · filed 2020-04-03 | ||||
| 2018-09-30 | $1.13M 10-Q · filed 2019-11-14 | $2.02M derived: sum of 2 quarters · filed 2019-11-14 | $2.82M 10-Q · filed 2019-11-14 | $4.36M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $883.85K 10-Q · filed 2019-08-14 | $1.69M 10-Q · filed 2019-08-14 | $3.23M derived: sum of 3 quarters · filed 2019-08-14 | $4.33M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $804.36K 10-Q · filed 2019-05-21 | $2.35M derived: sum of 2 quarters · filed 2019-05-21 | $3.45M derived: sum of 3 quarters · filed 2019-05-21 | $4.34M derived: sum of 4 quarters · filed 2019-05-21 | ||||
| 2017-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | $2.64M derived: sum of 2 quarters · filed 2019-04-10 | $3.54M derived: sum of 3 quarters · filed 2019-04-10 | $4.36M 10-K · filed 2019-04-10 | ||||
| 2017-09-30 | $1.10M 10-Q · filed 2018-11-19 | $2.00M derived: sum of 2 quarters · filed 2018-11-19 | $2.82M 10-Q · filed 2018-11-19 | $2.85M derived: sum of 4 quarters · filed 2018-11-19 | ||||
| 2017-06-30 | $896.52K 10-Q · filed 2018-08-13 | $1.72M 10-Q · filed 2018-08-13 | $1.75M derived: sum of 3 quarters · filed 2018-08-13 | $1.80M derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $822.41K 10-Q · filed 2018-05-15 | $851.29K derived: sum of 2 quarters · filed 2018-05-15 | $901.64K derived: sum of 3 quarters · filed 2018-05-15 | $925.79K derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $28.88K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-09 | $79.23K derived: sum of 2 quarters · filed 2018-04-09 | $103.38K derived: sum of 3 quarters · filed 2018-04-09 | $141.52K 10-K · filed 2018-04-09 | ||||
| 2016-09-30 | $50.36K 10-Q · filed 2017-11-20 | $74.50K derived: sum of 2 quarters · filed 2017-11-20 | $112.65K 10-Q · filed 2017-11-20 | |||||
| 2016-06-30 | $24.14K 10-Q · filed 2017-08-09 | $62.29K 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | $38.15K 10-Q/A · filed 2017-06-23 | |||||||
| 2015-12-31 | $258.38K 10-K · filed 2017-02-15 | |||||||
| 2015-06-30 | $63.14K 10-Q · filed 2016-08-15 | $125.53K 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | $62.39K 10-Q · filed 2016-05-10 | |||||||
| 2014-12-31 | $0.00 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |